These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge. Espinosa D, Mendy J, Manayani D, Vang L, Wang C, Richard T, Guenther B, Aruri J, Avanzini J, Garduno F, Farness P, Gurwith M, Smith J, Harris E, Alexander J. EBioMedicine; 2018 Jan; 27():61-70. PubMed ID: 29269041 [Abstract] [Full Text] [Related]
25. Enhanced effect of modified Zika virus E antigen on the immunogenicity of DNA vaccine. In HJ, Lee YH, Jang S, Lim HJ, Kim MY, Kim JA, Yoo JS, Chung GT, Kim YJ. Virology; 2020 Oct; 549():25-31. PubMed ID: 32818729 [Abstract] [Full Text] [Related]
27. Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus. Yang M, Dent M, Lai H, Sun H, Chen Q. Vaccine; 2017 Jul 24; 35(33):4287-4294. PubMed ID: 28669618 [Abstract] [Full Text] [Related]
35. Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model. Zhou Y, Chen D, Yang L, Zou W, Duan Z, Zhang Y, Wen J. Virus Res; 2020 Mar 24; 278():197882. PubMed ID: 31981774 [Abstract] [Full Text] [Related]